Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis
- PMID: 21484785
- DOI: 10.1002/eji.201041316
Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis
Abstract
Oxidative stress and inflammation--two components of the natural host response to injury--constitute important etiologic factors in atherogenesis. The pro-inflammatory cytokine interleukin (IL)-1 significantly enhances atherosclerosis, however, the molecular mechanisms of IL-1 induction within the artery wall remain poorly understood. Here we have identified the oxidative stress-responsive transcription factor NF-E2-related 2 (Nrf2) as an essential positive regulator of inflammasome activation and IL-1-mediated vascular inflammation. We show that cholesterol crystals, which accumulate in atherosclerotic plaques, represent an endogenous danger signal that activates Nrf2 and the NLRP3 inflammasome. The resulting vigorous IL-1 response critically depended on expression of Nrf2, and Nrf2-deficient apolipoprotein E (Apoe)-/- mice were highly protected against diet-induced atherogenesis. Importantly, therapeutic neutralization of IL-1α and IL-1β reduced atherosclerosis in Nrf2+/- Apoe-/- but not in Nrf2-/- Apoe-/- mice, suggesting that the pro-atherogenic effect of Nrf2-signaling was primarily mediated by its permissive role in IL-1 production. Our studies demonstrate a role for Nrf2 in inflammasome activation, and identify cholesterol crystals as disease-relevant triggers of the NLRP3 inflammasome and potent pro-atherogenic cytokine responses. These findings suggest a common pathway through which oxidative stress and metabolic danger signals converge and mutually perpetuate the chronic vascular inflammation that drives atherosclerosis.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.Circ Res. 2018 Jun 8;122(12):1722-1740. doi: 10.1161/CIRCRESAHA.118.311362. Circ Res. 2018. PMID: 29880500 Review.
-
NLRP3 inflammasome pathways in atherosclerosis.Atherosclerosis. 2017 Dec;267:127-138. doi: 10.1016/j.atherosclerosis.2017.10.027. Epub 2017 Oct 22. Atherosclerosis. 2017. PMID: 29126031 Review.
-
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1457-1461. doi: 10.1161/ATVBAHA.117.309575. Epub 2017 Jun 8. Arterioscler Thromb Vasc Biol. 2017. PMID: 28596375
-
3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.Biochem Pharmacol. 2016 Feb 1;101:71-86. doi: 10.1016/j.bcp.2015.11.015. Epub 2015 Nov 14. Biochem Pharmacol. 2016. PMID: 26588861
-
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.Nature. 2010 Apr 29;464(7293):1357-61. doi: 10.1038/nature08938. Nature. 2010. PMID: 20428172 Free PMC article.
Cited by
-
Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host-Pathogen Dynamics.Antioxidants (Basel). 2024 Apr 29;13(5):545. doi: 10.3390/antiox13050545. Antioxidants (Basel). 2024. PMID: 38790650 Free PMC article. Review.
-
The promising antioxidant effects of lignans: Nrf2 activation comes into view.Naunyn Schmiedebergs Arch Pharmacol. 2024 May 2. doi: 10.1007/s00210-024-03102-x. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38695909 Review.
-
Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities.Int J Mol Sci. 2024 Jan 9;25(2):821. doi: 10.3390/ijms25020821. Int J Mol Sci. 2024. PMID: 38255895 Free PMC article. Review.
-
Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease.Ann Med. 2023;55(2):2284890. doi: 10.1080/07853890.2023.2284890. Epub 2023 Dec 1. Ann Med. 2023. PMID: 38039549 Free PMC article. Review.
-
Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy.J Hematol Oncol. 2023 Nov 30;16(1):116. doi: 10.1186/s13045-023-01512-7. J Hematol Oncol. 2023. PMID: 38037103 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous